Driving compliance in fully remote Alzheimer’s trials is complex, ICON Concierge Services makes it possible. In a pre-clinical study with 600+ participants and over 50 ePROs per patient, Concierge direct-to-patient serv...
In the News
ICON experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
mHealth: Changing the Dynamics of the Healthcare Ecosystem
Vicki Anastasi discuss how mHealth is changing medical device clinical trials in this Pharmaceutical Executive article
-
Tackling RWE Challenges To Demonstrate Healthcare Value
A thought-leadership piece co-authored by Michael Pace and Jim Carroll, on the expected impact and challenges ofreal world evidence (RWE)on how healthcare technologies will be developed and consumed.
-
-
Must-Know FDA Guidance Documents from 2017
A thought-leadership piece co-authored by Cynthia Nolte, Sandra D. Maher, and Ashleigh Dawley on the new and updated guidance documents issued by the FDA in 2017, focusing on those important formedical manufacturersand the industry.
-
Access and Reimbursement for Adoptive T-Cell Transfer Drugs
ICON experts inoncology and pricing & market accessshare their thoughts on offsetting payer obstacles in this Pharmaceutical Executive article.
-
Europes New Medical Device Rules
Learn how you can avoid the expected delays and extra costs in your development process underMDR and IVDR Medical Device Regulations.
-
Bringing Precision Medicine to Traumatic Brain Injury Treatment
An article reporting on ICON's contribution to a complex pan-European traumatic brain injury (TBI) research study.
-
Trending 2018: What Does the Future Hold?
Trending 2018: What Does the Future Hold?- featuring commentary from PV100 honouree Bill Byrom, on prevailing trends in the industry.
-
Building a Comprehensive Real World Evidence Strategy
ICON’s Jim Carroll outlines how a fully integrated, multidisciplinary RWE model can save time, money and effort in study development and execution, for better commercial outcomes.
-
Adaptive Clinical Trial Designs Are Innovative
Article featuring commentary from Rolf Hvelmann and Parvin Fardipour on tackling the operational challenges of adaptive trials.
